Evaluation Efficacy of Tranexamic acid in decreasing blood loss
Phase 3
- Conditions
- Blood loss after cesarean.
- Registration Number
- IRCT20140420017365N4
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Candidate for Elective Singleton Cesarean section
Having adequate prenatal care.
Complete the form of informed consent
Age range 18-45 years
Exclusion Criteria
Patients do not accept to participate in the study
They have anemia and bleeding diseases or serious medical or surgical diseases
Sensitivity to Tranexamic acid
Fetal macrosomia
Thromboembolism Score(V.T.E. scoring)=3
Placental Abruption , placenta parvia and abnormal placental adherence
Uterine myoma more than 5 cm
Polyhydramnios
Multi-fetus pregnancy
Use of Anticoagulant such as enoxaparin or heparin
Severe pregnancy complications such as preeclampsia
Long-term hospitalization more than 3 days before cesarean section
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ?Blood loss. Timepoint: After cesarean section. Method of measurement: Bleeding volume including suctioned blood volume, weight of all draw sheets changed up to 6 hours after surgery.;Blood transfusion. Timepoint: Blood transfusions and blood products at admission time. Method of measurement: number of transfused blood products.
- Secondary Outcome Measures
Name Time Method